NCT06071065

Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients

Name: Clinical Trial NCT06071065
Creator: Hamdard University
Keywords: Chronic Kidney Disease, Pharmacist counselling, behavioral, clinical trial, Pakistan

Impact of Clinical Pharmacist Intervention on Medication Adherence and Its Association With Clinical Outcomes in Chronic Kidney Disease in Islamabad

Hamdard University·ClinicalTrials.gov·behavioralRecruitment Completed

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Chronic Kidney Disease
Drug/Device/Intervention: Pharmacist counselling
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Hamdard University
Location: Islamabad, Pakistan

Timeline & enrollment

Phase: N/A
Start date: Sep 22, 2023
End date: Apr 20, 2024
Enrollment: 130 participants

Primary outcome

Health related Quality of Life,Patients Medication Adherence.

Summary

The purpose of this research study is to evaluate the impact of clinical pharmacist interventions on treatment outcomes, health-related quality of life (HRQoL),and medication adherence among chronic kidney disease patients.  Pharmacist's intervention aim to answer:  1. How a clinical pharmacist intervention program impact medication adherence in chronic kidney disease?  2. To assess how patients' counseling and medication adherence impact patient health-related quality of life?  3. How a clinical pharmacist intervention program improves clinical outcomes of chronic kidney disease patients?

ICD-10 classifications

Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06071065
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06071065 through Pure Global AI's free database. This phase not specified trial is sponsored by Hamdard University and is currently Recruitment Completed. The study focuses on Chronic Kidney Disease. Target enrollment is 130 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.